Evidence map›Paper›PMID 32880391›Full record

ArticleBioscience reports2020

Promiscuous DNA cleavage by HpyAII endonuclease is modulated by the HNH catalytic residues.

Sumith Kumar, Sushant Bangru, Ritesh Kumar, Desirazu N Rao

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sumith Kumar *Department of Biochemistry, Indian Institute of Science, CV Raman Road, Bangalore, India.
Sushant BangruDepartment of Biochemistry, Indian Institute of Science, CV Raman Road, Bangalore, India.
Ritesh KumarDepartment of Biochemistry, Indian Institute of Science, CV Raman Road, Bangalore, India.
Desirazu N RaoDepartment of Biochemistry, Indian Institute of Science, CV Raman Road, Bangalore, India.
Indian Institute of Science Bangalore · INJawaharlal Nehru Centre for Advanced Scientific Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helicobacter pylori is a carcinogenic bacterium that is responsible for 5.5% of all human gastric cancers. H. pylori codes for an unusually large number of restriction-modification (R-M) systems and several of them are strain-specific and phase-variable. HpyAII is a novel Type IIs phase-variable restriction endonuclease present in 26695 strain of H. pylori. We show that HpyAII prefers two-site substrates over one-site substrates for maximal cleavage activity. HpyAII is less stringent in metal ion requirement and shows higher cleavage activity with Ni2+ over Mg2+. Mutational analysis of the putative residues of the HNH motif of HpyAII confirms that the protein has an active HNH site for the cleavage of DNA. However, mutation of the first Histidine residue of the HNH motif to Alanine does not abolish the enzymatic activity, but instead causes loss of fidelity compared with wildtype HpyAII. Previous studies have shown that mutation of the first Histidine residue of the HNH motif of all other known HNH motif motif-containing enzymes completely abolishes enzymatic activity. We found, in the case of HpyAII, mutation of an active site residue leads to the loss of endonuclease fidelity. The present study provides further insights into the evolution of restriction enzymes.

Indexed as

Bacterial ProteinsBinding SitesCatalytic DomainCations, DivalentCoenzymesDeoxyribonucleases, Type II Site-SpecificDNA CleavageHelicobacter pyloriMagnesiumMutagenesis, Site-DirectedNickelSubstrate SpecificityBacterial ProteinsCations, DivalentCoenzymesDeoxyribonucleases, Type II Site-SpecificMagnesiumNickeldirected evolutionendonucleasesHelicobacter pylorirestriction-modification systemsite-directed mutagenesis

Identifiers

PMID32880391
PMCPMC7494987
OpenAlexW3083143903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.